CD + 8 T-cell peptides interactions |
LTDEMIAQY + HLA-B*53:01 |
−9.54 |
LYS-146, TYR-84, ASN-77, GLU-76, THR-73, ASN-70, ARG-97 and TYR-99
|
Salt bridges, hydrogen bond, Pi-cation, Pi-anion, Pi-Pi stacked and Akyl |
WTAGAAAYY + HLA-B*44:03 |
−8.80 |
GLU-76, THR-80, ALA-81, ILE-95, ASP-116, TYR-123, LYS-146, TRP-147, ALA-158, LEU-163 and GLU-166
|
Salt bridges, hydrogen bond, Pi-cation, Pi-anion, Pi-Pi stacked, Amide-Pi stacked and Pi-Akyl |
WMESEFRVY + HLA-B*44:03 |
−9.22 |
THR-73 GLU-76 ARG-83, TYR-84, ARG-97, ASP-114, ASP-116, LYS-146 TRP-147, ALA-149, ALA-150 and LEU-156
|
Hydrogen bond, Pi-Pi stacked and Pi-Akyl |
CD + 4 T-cell peptides interactions |
IRASANLAA + HLA-DRB1*01:01 |
−10.63 |
GLN-09, PHE-32, PHE-54, ASN-62, LEU-67, GLN-70, ARG-71 and TYR-78
|
Hydrogen bond, Pi-Sigma, Akyl and Pi-Akyl |
VKQLSSNFG + LA-DRB1*01:01 |
−8.74 |
GLN-09, PHE-13, GLY-58, TYR-60, TRP-61, ASN-62, GLN-64, VAL-65, ASN-69, ARG-71 and TYR-78
|
Hydrogen bond, Akyl and Pi-Akyl |
FAMQMAYRF + HLA-DRB1*01:01 |
−8.59 |
PHE-13, PHE-24, SER-53, GLY-58, ASN-62, VAL-65, GLN-70, ARG-71, THR-77, TRY-78, ASN-82 and VAL-85
|
Hydrogen bond, Pi-cation, Pi-sulfur, Pi-Pi T-shaped and Pi-Akyl |
FGAGAALQ + HLA-DRB1*01:01 |
−9.28 |
ILE-07, GLN-09, ILE-31, SER-53, ASN-62, VAL-65, GLN-70, ARG-71, ALA-74 and ASN-82
|
Salt bridges, hydrogen bond, Akyl and Pi-Akyl |
FGAISSVLN + HLA-DRB1*01:01 |
−12.19 |
GLN-09, PHE-13, PRO-56, TYR-60, TRP-61, ASN-62, LEU-67, ASN-69, GLU-71, ALA-74, LYS-75, LYS-75, ATG-76 and TYR-78
|
Salt bridges, hydrogen bond, Pi-Pi stacked, Pi-Pi T-shaped and Akyl and Pi-Akyl |